ALBERT DAVID
|
ALBERT DAVID Last 5 Year Financial Ratios History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 132.15 | 63.38 | 61.78 | 38.80 | 33.59 |
| CEPS(Rs) | 144.11 | 78.36 | 77.21 | 53.22 | 47.03 |
| DPS(Rs) | 11.50 | 9.00 | 9.00 | 6.00 | 7.00 |
| Book NAV/Share(Rs) | 671.05 | 545.93 | 489.68 | 428.20 | 390.38 |
| Tax Rate(%) | 22.48 | 28.70 | 25.45 | 19.31 | 33.80 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 12.25 | 12.33 | 12.38 | 7.40 | 9.04 |
| EBIT Margin(%) | 25.48 | 14.23 | 14.51 | 10.84 | 8.87 |
| Pre Tax Margin(%) | 25.37 | 14.07 | 14.30 | 10.54 | 8.58 |
| PAT Margin (%) | 19.67 | 10.03 | 10.66 | 8.50 | 5.68 |
| Cash Profit Margin (%) | 21.45 | 12.40 | 13.33 | 11.66 | 7.95 |
| Performance Ratios | |||||
| ROA(%) | 13.51 | 7.33 | 8.01 | 5.51 | 4.95 |
| ROE(%) | 21.72 | 12.24 | 13.46 | 9.48 | 8.85 |
| ROCE(%) | 27.84 | 17.10 | 18.10 | 11.99 | 13.74 |
| Asset Turnover(x) | 0.69 | 0.73 | 0.75 | 0.65 | 0.87 |
| Sales/Fixed Asset(x) | 1.69 | 1.62 | 1.52 | 1.23 | 1.67 |
| Working Capital/Sales(x) | 1.41 | 1.76 | 2.26 | 1.83 | 2.81 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.59 | 0.62 | 0.66 | 0.81 | 0.60 |
| Receivable days | 28.39 | 28.00 | 24.56 | 34.76 | 28.06 |
| Inventory Days | 44.87 | 45.48 | 41.36 | 54.98 | 46.93 |
| Payable days | 132.65 | 130.63 | 115.22 | 164.75 | 166.80 |
| Valuation Parameters | |||||
| PER(x) | 8.14 | 8.08 | 8.61 | 9.71 | 9.58 |
| PCE(x) | 7.46 | 6.53 | 6.89 | 7.08 | 6.84 |
| Price/Book(x) | 1.60 | 0.94 | 1.09 | 0.88 | 0.82 |
| Yield(%) | 1.07 | 1.76 | 1.69 | 1.59 | 2.18 |
| EV/Net Sales(x) | 1.62 | 0.80 | 0.92 | 0.73 | 0.56 |
| EV/Core EBITDA(x) | 5.60 | 4.54 | 5.10 | 4.97 | 4.76 |
| EV/EBIT(x) | 5.99 | 5.29 | 6.03 | 6.42 | 5.98 |
| EV/CE(x) | 1.52 | 0.86 | 0.61 | 0.45 | 0.45 |
| M Cap / Sales | 1.69 | 0.86 | 0.97 | 0.87 | 0.57 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 6.12 | 8.95 | 26.70 | -22.86 | 1.13 |
| Core EBITDA Growth(%) | 74.62 | 5.45 | 55.72 | -3.07 | -25.87 |
| EBIT Growth(%) | 90.41 | 6.98 | 69.94 | -5.72 | -31.52 |
| PAT Growth(%) | 108.49 | 2.60 | 59.23 | 15.52 | -28.05 |
| EPS Growth(%) | 108.49 | 2.60 | 59.23 | 15.52 | -28.05 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 |
| Current Ratio(x) | 2.33 | 2.09 | 1.81 | 2.05 | 1.81 |
| Quick Ratio(x) | 2.11 | 1.82 | 1.59 | 1.79 | 1.52 |
| Interest Cover(x) | 226.30 | 87.91 | 71.35 | 36.00 | 30.41 |
| Total Debt/Mcap(x) | - | 0.02 | 0.02 | 0.01 | 0.01 |
Compare Financial Ratios of peers of ALBERT DAVID
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALBERT DAVID | ₹742.1 Cr | -5.7% | -13.6% | 26.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹438,143.0 Cr | -1.2% | 0.9% | 41.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹154,578.0 Cr | -3.7% | -1.8% | 46.1% | Stock Analytics | |
| CIPLA | ₹120,185.0 Cr | -1.5% | 2.2% | 16.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,450.0 Cr | 1.4% | 10.6% | 17.2% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹101,569.0 Cr | 3.5% | 3.6% | 37.4% | Stock Analytics | |
ALBERT DAVID Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALBERT DAVID | -5.7% |
-13.6% |
26.4% |
| SENSEX | -2.9% |
-4.8% |
8% |
You may also like the below Video Courses
